• Evolocumab reduces LDL particle sizes in hyperlipidemia

    One year ago - By Healio

    Patients with hyperlipidemia treated with evolocumab had a greater reduction in atherogenic lipoprotein particles compared with those who received placebo, according to a post hoc subanalysis published in The American Journal of Cardiology.
    Peter P. Toth, MD, PhD, FAHA, FESC, FACC, director of preventive cardiology at CGH Medical Center in Sperling, Illinois; professor of clinical family and community medicine at University of Illinois College of Medicine in Peoria; and professor of medicine at Michigan State University College of Osteopathic Medicine in East Lansing, and colleagues analyzed
    Read more ...